Connect with us

CBD News

University of Maryland School of Pharmacy Launches Cannabis Science and Therapeutics Program



University of Maryland School of Pharmacy Launches Cannabis Science and Therapeutics Program

According to a press release that appeared in the Cannabis Business Times, the University of Maryland School of Pharmacy has launched a new program, called a Master of Science in Medical Cannabis Science and Therapeutics.

The program will provide students with the knowledge and skills that they need to help patients in the medical cannabis industry. They’ll also work to provide more research and knowledge in the field, and to develop medical cannabis policies. The program is for two years and it combines online learning with in-class teaching experiences.

According to Natalie D. Eddington, PhD, FCP, FAAPS, dean and professor at the School of Pharmacology,

“Medical cannabis has been legalized in 33 states, including Maryland, as well as in Washington, D.C., Guam, and Puerto Rico. This number is only expected to increase in the future, fueling a demand for an educated workforce that is well-trained in both the science and therapeutic effects associated with this medicinal plant. Our MS in Medical Cannabis Science and Therapeutics has been critically designed to prepare students to meet this demand. Innovations in instructional design throughout the curriculum will provide students with the knowledge and skills needed to make a positive impact on communities across the United States.”

Despite medical cannabis legalization in several states, marijuana remains illegal under federal law. Those who go through the program will learn areas concerning basic science, clinical use, public health, and adverse effects. The coursework is both online and in-person. There is also an in-person symposia that occurs each semester at USG that allows students to network the peers and to meet experts in the field.

According to Leah Sera, PharmaD, MA, BCPS, assistant professor in the Department of Pharmacy Practice and Science at UMSOP, director of the MS in Medical Cannabis Science and Therapeutics Program, and a clinical pharmacist practicing in the field if palliative care,

“The MS in Medical Cannabis Science and Therapeutics is an incredibly unique program,” and “Faculty from the School of Pharmacy who lead courses for the program are experts in both basic and clinical sciences related to the study of medications, and are dedicated to making coursework both interesting and accessible to all students.”

She added, “There is truly no other educational program that offers the in-depth instruction on the science, policy, and therapeutics of medical cannabis that students who are accepted into our program will receive.” The press release can be read here.

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.